Cadralazine
Jump to navigation
Jump to search
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H21N5O3 |
Molar mass | 283.332 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class.[1]
References
- ^ McTavish D, Young RA, Clissold SP (October 1990). "Cadralazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension". Drugs. 40 (4): 543–60. doi:10.2165/00003495-199040040-00005. PMID 2083513.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Secondary alcohols
- Carbamates
- Hydrazides
- Pyridazines
- Ethyl esters
- All stub articles
- Antihypertensive agent stubs